Basit öğe kaydını göster

dc.contributor.authorYazıcı, Bülent
dc.contributor.authorOral, Aylin
dc.contributor.authorÖmür, Özgür
dc.contributor.authorYazıcı, Ayşe
dc.date.accessioned2020-11-20T15:06:38Z
dc.date.available2020-11-20T15:06:38Z
dc.date.issued2015
dc.identifier.issn0363-9762
dc.identifier.issn1536-0229
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3155
dc.descriptionWOS: 000348148700017en_US
dc.descriptionPubMed ID: 25140551en_US
dc.description.abstractA 28-year-old woman underwent a near-total thyroidectomy for papillary carcinoma. Before radioiodine therapy, the serum thyroid-stimulating hormone level was 50 mu IU/mL, the thyroglobulin level was 1 mu g/L, and the antithyroglobulin was negative. She received 100 mCi of I-131 for ablation of residual thyroid tissue. After therapy, I-131 whole-body scan demonstrated focal uptake in the right pelvic area, which localized to the right ovary on SPECT/CT fusion images. The ovarian cyst was resected, and histopathological examination revealed a mature teratoma without thyroid tissue component. At 6-month follow-up, the whole-body radioiodine scan was normal, and serum thyroglobulin was undetectable.en_US
dc.item-language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRadioiodine Uptakeen_US
dc.titleRadioiodine Uptake in an Ovarian Mature Teratoma Detected With SPECT/CTen_US
dc.item-typeeditorialen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Eğitim ve Araştırma Hastanesien_US
dc.contributor.institutionauthorYazıcı, Ayşe
dc.identifier.volume40en_US
dc.identifier.issue2en_US
dc.identifier.startpageE157en_US
dc.identifier.endpageE160en_US
dc.relation.journalClinical Nuclear Medicineen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster